Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Schedule of Reconciliation of Net Loss to Net Loss Attributable to Heat Biologics, Inc. (Details)

v3.20.2
Net Loss Per Share - Schedule of Reconciliation of Net Loss to Net Loss Attributable to Heat Biologics, Inc. (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Net Loss Per Share        
Net loss $ (8,916,433) $ (6,330,913) $ (19,826,671) $ (17,094,899)
Net loss: Non-controlling interest (64,824) (136,315) (228,526) (413,955)
Net loss attributable to Heat Biologics, Inc. $ (8,851,609) $ (6,194,598) $ (19,598,145) $ (16,680,944)
Weighted-average number of common shares used in net loss per share attributable to Heat Biologics, Inc.-basic and diluted 143,728,870 33,650,829 96,481,271 33,255,535
Net loss per share applicable to Heat Biologics, Inc - basic and diluted $ (0.06) $ (0.18) $ (0.20) $ (0.50)